Skip to main content
. 2016 Mar;22(3):10.18553/jmcp.2016.22.3.209. doi: 10.18553/jmcp.2016.22.3.209

TABLE 4.

Rationale for Stopping (Early Biologic Fillers and Late Biologic Fillers) and Not Filling (Nonfillers) bDMARDs

All Patients (N = 373) Early Biologic Fillersa (n = 170) Late Biologic Fillersb (n = 59) Nonfillersc (n = 144)
Any reason, n (%) 47 (12.6) 14 (8.2) 12 (20.3) 21 (14.6)
  Cost 4 (8.5) 1 (7.1) 1 (8.3) 2 (9.5)
  Efficacy 6 (12.8) 2 (14.3) 2 (16.7) 2 (9.5)
  Side effects 10 (21.3) 3 (21.4) 3 (25.0) 4 (19.0)
  No reason given 39 (83.0) 12 (85.7) 8 (66.7) 19 (90.5)

abDMARD prescription filled within 30 days of index bDMARD.

bbDMARD prescription filled within 31-180 days of index bDMARD.

cbDMARD prescription not filled at all within 180 days of index bDMARD.

bDMARD = biologic disease-modifying antirheumatic drug.